Aseptuva is a Swiss medtech startup, with the goal to prevent Hospital Acquired Infections (HAI).
Aseptuva has raised €601k across 2 funding rounds from 3 investors, most recently a round in Oct 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-10-06 | Other | €88k | Tech4Impact | View deal → |
| 2022-08-30 | Pre-Seed | €513k | Fortyone AG,Valuemaker AG | View deal → |
